Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus

Brain Research

Volumn 1018, Issue 1, 2004, Pages 10-17

  Ma, Li ^a   Nicholson, Louise F B ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Astrocyte; Degenerative disease: Huntington's disease; Disorders of the nervous system and aging; Huntington's disease; Immunohistochemistry; Neuron; Receptor for advanced glycation end products; Subependymal layer

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BRAIN RECEPTOR; LIGAND;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CAUDATE NUCLEUS; CELL COUNT; CELL STRUCTURE; CELL TYPE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL NECROSIS; NERVE PROJECTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; ASTROCYTES; CAUDATE NUCLEUS; CELL COUNT; CELL DEATH; CELL NUCLEUS; EPENDYMA; FEMALE; HUMANS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; LIGANDS; MALE; MIDDLE AGED; NEURONS; RECEPTORS, IMMUNOLOGIC;

EID: 3242726002     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.05.052     Document Type: Article

References (29)

1. Curtis M.A., Penney E.B., Pearson A.G., van Roon-Mom W.M., Butterworth N.J., Dragunow M., Connor B., Faull R.L. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc. Natl. Acad. Sci. U. S. A. 100:2003;9023-9027
2. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9:2003;907-913
3. Dickson D.W., Lee S.C., Brosnan C.F., Sinicropi S., Vlassara H., Yen S.C. Neuroimmunology of aging and Alzheimer's disease with emphasis on cytokines. Ransohoff R.M., Benveniste E.N. Cytokines and the CNS Defence; Development, Defence and Disease. 1996;239-267 CRC Press, Boca Raton, FL
4. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta. 1450:1999;191-231
5. Du Yan S., Zhu H., Fu J., Yan S.F., Roher A., Tourtellotte W.W., Rajavashisth T., Chen X., Godman G.C., Stern D., Schmidt A.M. Amyloid-beta peptide-receptor for advanced glycation end product interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5296-5301
6. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L. III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7611-7615
7. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97:1999;889-901
8. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275:2000;40096-40105
9. Kligman D., Marshak D.R. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. U. S. A. 82:1985;7136-7139
10. Lue L.F., Walker D.G., Brachova L., Beach T.G., Rogers J., Schmidt A.M., Stern D.M., Yan S.D. Involvement of microglial receptor for advanced glycation end products (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 171:2001;29-45
11. Ma L., Carter R.J., Morton A.J., Nicholson L.F. RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats. Brain Res. 966:2003;167-174
12. Manev H., Uz T., Manev R. Glia as a putative target for antidepressant treatments. J. Affect. Disord. 75:2003;59-64
13. McGowan D.P., van Roon-Mom W., Holloway H., Bates G.P., Mangiarini L., Cooper G.J., Faull R.L., Snell R.G. Amyloid-like inclusions in Huntington's disease. Neuroscience. 100:2000;677-680
14. Myers R.H., Vonsattel J.P., Paskevich P.A., Kiely D.K., Stevens T.J., Cupples L.A., Richardson E.P. Jr., Bird E.D. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J. Neuropathol. Exp. Neurol. 50:1991;729-742
15. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267:1992;14998-15004
16. Oorschot D.E. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical dissector methods. J. Comp. Neurol. 366:1996;580-599
17. Perutz M.F., Johnson T., Suzuki M., Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. U. S. A. 91:1994;5355-5358
18. Sasaki N., Fukatsu R., Tsuzuki K., Hayashi Y., Yoshida T., Fujii N., Koike T., Wakayama I., Yanagihara R., Garruto R., Amano N., Makita Z. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am. J. Pathol. 153:1998;1149-1155
19. Sasaki N., Toki S., Chowei H., Saito T., Nakano N., Hayashi Y., Takeuchi M., Makita Z. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res. 888:2001;256-262
20. Sasaki N., Takeuchi M., Chowei H., Kikuchi S., Hayashi Y., Nakano N., Ikeda H., Yamagishi S., Kitamoto T., Saito T., Makita Z. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques. Neurosci. Lett. 326:2002;117-120
21. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta. 1498:2000;99-111
22. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Ukitsu M., Genda Y. Decrease with age in methylcytosines in the promoter region of receptor for advanced glycated end products (RAGE) gene in autopsy human cortex. Mol. Brain Res. 65:1999;124-128
23. Van Eldik L.J., Zimmer D.B. Secretion of S-100 from rat C6 glioma cells. Brain Res. 436:1987;367-370
24. Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57:1998;369-384
25. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Jr. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577
26. Vonsattel J.P., Ge P., Kelley L. Huntington's disease. Esiri M.M., Morris J.H. The Neuropathology of Dementia. 1987;219-240 Cambridge, Oxford
27. Winningham-Major F., Staecker J.L., Barger S.W., Coats S., Van Eldik L.J. Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues. J. Cell. Biol. 109:1989;3063-3071
28. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691
29. Yan S.D., Zhu H., Zhu A., Golabek A., Du H., Roher A., Yu J., Soto C., Schmidt A.M., Stern D., Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 6:2000;643-651